Clinical Trials Directory

Trials / Completed

CompletedNCT03906877

Early UVFP Management Based on Neurological Evidences (UVFP = Unilateral Vocal Fold Paralysis)

Early UVFP Management Based on Neurological Evidences UVFP = Unilateral Vocal Fold Paralysis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to understand how early intervention could impact reinnervation of the recurrent laryngeal nerve (which innervates the vocal cord), recovery of mobility of the paralyzed vocal cord and / or vocal recovery in the case of unilateral vocal fold paralysis. To achieve this goal we must therefore carry out a complete outcomes assessment of different intervention methods (voice therapy and injection laryngoplasty), which are offered to UVFP (unilateral vocal fold paralysis) patients in the early stage (\< 3 months). Their respective impacts on the central and peripheral nervous system and on the voice quality will be assessed, taking into account factors related to the severity of the paralysis.

Conditions

Interventions

TypeNameDescription
PROCEDUREAcid hyaluronic injection laryngoplastyHyaluronic acid is injected into the paralyzed vocal fold
BEHAVIORALVoice therapy15 sessions of thirty minutes of voice therapy, twice a week, and home practice. This voice management will be specific to unilateral vocal fold paralysis and will focus on three objectives: reinforcement of the vocal muscle, glottal closure and glottal opening. These three objectives will be worked through different vocal exercises (on voiced phonemes) and breathing exercises
OTHERSham of injectionInjection of physiological saline under the skin of the neck (sham of injection).
OTHERSham of voice therapy15 sessions of thirty minutes of voice therapy, twice a week, and home practice. This voice management will not be specific to UVFP but may allow patients to improve their vocal gesture.

Timeline

Start date
2019-11-15
Primary completion
2023-09-30
Completion
2023-09-30
First posted
2019-04-08
Last updated
2023-11-24

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03906877. Inclusion in this directory is not an endorsement.